Global Non-electric Intravenous Infusion Pump Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Elastomeric Infusion Pumps and Mechanical Pumps), By Application (Oncology, Pediatrics/Neonatology, Pain Management, Diabetes, Gastroenterology, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Non-electric Intravenous Infusion Pump Market Size Insights Forecasts to 2035

• The Global Non-electric Intravenous Infusion Pump Market Size Was Estimated at USD 620.0 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.63% from 2025 to 2035
• The Worldwide Non-electric Intravenous Infusion Pump Market Size is Expected to Reach USD 1020.0 Million by 2035

Key Takeaways -

• North America dominated the market with the largest share in 2024. 
• Asia Pacific is expected to grow the fastest during the forecast period.
• By product type, the elastomeric infusion pumps segment dominates the non-electric intravenous infusion pumps market, while mechanical pumps segment is the emerging segment in the market.
• By application, the oncology segment dominated the market with a significant share of about 35.0%, on the other hand, the pain management segment is emerging in the market with a CAGR of about 4.1%.
• By end user, the hospitals segment dominated the non-electric intravenous infusion pump market, while the ambulatory surgical centers segment is anticipated to grow at a CAGR of about 4.2% during the forecast period.

According to a Research Report Published by Spherical Insights and Consulting, The Global Non-electric Intravenous Infusion Pump Market Size was worth around USD 620.0 Million in 2024 and is predicted to Grow to around USD 1020.0 Million by 2035 with a compound annual growth rate (CAGR) of 4.63% from 2025 and 2035. The market for non-electric intravenous infusion pumps has a number of opportunities to grow due to the development of cost-effective, portable devices for ambulatory chemotherapy and pain management, and reducing hospital stays.

Market Overview

The global non-electric intravenous infusion pump industry refers to the market encompassing portable, mechanical devices, principally elastomeric pumps that deliver fluids or medications without electricity. A non-electric intravenous infusion pump is ideally used for outpatient therapy, chemotherapy, and continuous antibiotic delivery. The pump typically uses pressure from elastomeric balloons, springs, or gravity to deliver fluids. Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and expanding partnerships. For instance, in October 2025, OSAA innovation developed innovative medical devices and smart connected solutions to revolutionize intravenous (IV) therapy, focusing on improving patient mobility, convenience, safety, and overall quality of life.     

Report Coverage

This research report categorizes the non-electric intravenous infusion pump market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the non-electric intravenous infusion pump market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the non-electric intravenous infusion pump market. 

Driving Factors

Increasing prevalence of chronic conditions and the number of surgical procedures

The growing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders, with an increasing ageing population, is driving the demand for non-electric/disposable, low-cost, portable pneumatic reliable IV infusion devices for consistent, long-term medication management, especially in home care and low-resource settings. In surgery procedure, these non-electric IV infusion pumps are used for continuous, low-pressure delivery of anesthetics, antibiotics, or chemotherapy.

Shift towards home-based care and need for a low-cost alternative to electronic pumps

Due to a shift towards home health driven by several reasons like digital mode of care delivery, demand for telemedicine platforms and AI-powered medical solutions, the market demand for non-electric intravenous infusion pumps is increasing as it is widely used in home health care. The surging need for low-cost alternatives to traditional electronic IV infusion pumps for improving patient safety and increasing access to essential care in low-resource settings contributes to propelling market demand.  

Restraining Factors

Limited usage in high-acuity clinical settings

Non-electric intravenous infusion pumps, typically elastomeric infusion devices, are portable, disposable, and operate using pressure rather than electricity, making them ideal for ambulatory care, home infusion, and lower acuity hospital settings and not for high-acuity clinical settings.

Market Segmentation

The Non-electric Intravenous Infusion Pump Market share is classified into product type, application, and end user.   

• The elastomeric infusion pumps segment dominated the market with the largest share of about 85.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the non-electric intravenous infusion pump market is divided into elastomeric infusion pumps and mechanical pumps. Among these, the elastomeric infusion pumps segment dominated the market with the largest share of about 85.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period. This is due to its widespread use in ambulatory care, post-operative pain management, and home infusion therapies. Elastomeric infusion pumps (EMPs) are safe and effective for administering outpatient intravenous (IV) antibiotics. While the mechanical pumps segment is the emerging segment in the non-electric intravenous infusion pump market, due to growing preference for low-maintenance and cost-efficient infusion solutions, especially in resource-limited environments.

• The oncology segment dominated the market with a significant market share of about 34.9% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the application, the non-electric intravenous infusion pump market is divided into oncology, paediatrics/neonatology, pain management, diabetes, gastroenterology, and other applications. Among these, the oncology segment dominated the market with a significant market share of about 34.9% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Non-electric, portable IV infusion pumps for oncology deliver chemotherapy continuously without electricity, enabling cancer patients to receive treatment at home, improving quality of life. Further, the pain management segment is a growing segment driven by the rising application of elastomeric pumps for post-operative analgesia and regional anesthesia for continuous pain relief.

• The hospitals segment dominated the market with a significant market share of around 45.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the non-electric intravenous infusion pump market is divided into hospitals, ambulatory surgical centers, home care settings, and other end users. Among these, the hospitals segment dominated the market with a significant market share of around 45.0% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Non-electric intravenous infusion systems are used in hospitals, preferably enhancing patient mobility and safety. An increasing number of surgical procedures, oncology treatments, and inpatient therapies are the factors driving the segmental market growth. The ambulatory surgical centres are growing rapidly, due to the increasing volume of day-care surgeries and the need for portable infusion solutions.

Regional Segment Analysis of the Non-electric Intravenous Infusion Pump Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the Non-electric Intravenous Infusion Pump market over the predicted timeframe.

North America is anticipated to hold the largest share of about 40.5% in the Non-electric Intravenous Infusion Pump market over the predicted timeframe. The market ecosystem in North America is strong, due to its increased demand across hospitals, ambulatory centres, and home infusion providers, as well as the presence of leading manufacturers in the region. The U.S. is leading the North America non-electric intravenous infusion pump market, due to the increased focus on home healthcare along with an increasing prevalence of chronic disease.

Asia Pacific is expected to grow at a rapid CAGR of approximately 6.0% during the forecast period. The Asia Pacific area has a thriving market for non-electric intravenous infusion pump due to the increasing healthcare investment along with an increasing number of surgical procedures. Due to their governments’ increasing healthcare spending and preference for homecare treatment, there is a growing demand for non-electric intravenous infusion pump. China is the leading country in the Asia Pacific market, owing to rapid infrastructure development, a growing elderly population, and home care adoption.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Non-electric intravenous infusion pump market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Ambu
• AVANOS
• B. Braun
• Baxter
• Epic Health EMEA
• Go Medical Industries
• Multimedical
• NIPRO
• Technoline
• VYGON 
• AVANOS
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development 

• In November 2024, Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, announced that LUMISIGHT (pegulicianine) was granted a permanent Healthcare Common Procedure Coding System (HCPCS) code for Hospital Outpatient Prospective Payment System (OPPS) by the Centers for Medicare & Medicaid Services (CMS).

• In August 2024, Innovative Health Sciences, a medical device company that creates state-of-the-art drug infusion solutions, announced the expansion of its commercialization team to market the Insignis Syringe Infusion System.

• In July 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system.

• In February 2023, Medical device company, Vygon, and University Hospital of Wales joined forces to deliver palliative at-home treatment for advanced heart failure patients in Wales. The portable elastomeric infusion pump is designed for the accurate delivery of continuous flow infusions over a sustained period and was successfully used on patients after being assessed and produced by the hospital pharmacy.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Non-electric Intravenous Infusion Pump Market based on the below-mentioned segments:

Global Non-electric Intravenous Infusion Pump Market, By Product Type

• Elastomeric Infusion Pumps
• Mechanical Pumps

Global Non-electric Intravenous Infusion Pump Market, By Application

• Oncology
• Pediatrics/Neonatology
• Pain Management
• Diabetes
• Gastroenterology
• Other Applications

Global Non-electric Intravenous Infusion Pump Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Other End Users

Global Non-electric Intravenous Infusion Pump Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa